EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dose-dependent activation of the Hippo pathway by Type I and Type III interferons suppresses tissue repair by human bronchial epithelial cells

Krupakar V Subramaniam, Hui Jing Lim, Bao Wang, Valia T Mihaylova, Evrett N Thompson, Diane S Krause, Ellen F Foxman iD

PLOS Biology · 2026

DOI: 10.1371/journal.pbio.3003615 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Biology, 2026. Verfasst von Krupakar V Subramaniam und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America. Hauptthemen laut MEDLINE: Protein Serine-Threonine Kinases, Epithelial Cells, Bronchi, Interferons. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NCATS NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interferons (IFNs) are potent antiviral cytokines that are rapidly activated when infected cells sense a virus, but continued IFN production following acute infection is linked to impaired recovery. IFNs protect against infection by inducing a suite of antiviral effectors in IFN receptor-expressing cells via JAK/STAT signaling. However, how IFNs curtail tissue repair is not fully understood. Here, we studied the effects of Type III IFNs (IFNλ1 and IFNλ2) and Type I IFN (IFNβ) on tissue repair functions of human bronchial epithelial cells (HBEC). We show that both Type III IFNs and IFNβ reduce bronchial epithelial cell migration and proliferation through a common upstream mechanism: activation of LATS1, a kinase best known for limiting organ growth as part of the Hippo signaling pathway. Mechanistically, Type III IFN or IFNβ curtailed wound healing by triggering phosphorylation of LATS1 via JAK activity, bypassing activation of MST1/2, the canonical activator of LATS1 in the Hippo pathway. Further experiments showed that distinct signaling pathways lead to LATS1 and STAT1 phosphorylation downstream of IFN receptor signaling. STAT1 was dispensable for IFN-mediated LATS1 phosphorylation and suppression of tissue repair, although as expected STAT1 was required for IFN-mediated protection from rhinovirus or influenza infection. Dose–response curve experiments revealed that higher concentrations of IFN were required to trigger LATS1 phosphorylation compared to STAT1 phosphorylation. Consistently, during rhinovirus or influenza virus infection of organotypic HBEC cultures, we observed phosphorylation of both LATS1 and STAT1, but with different kinetics, with LATS1 activation showing earlier resolution compared to STAT1 activation. These results provide a conceptual framework for understanding how IFN receptor signaling differentially controls epithelial functions required for tissue repair and antiviral defense, and inform efforts to target pathological effects of IFNs following viral infection and in other high IFN states.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Serine-Threonine KinasesEpithelial CellsBronchiInterferonsWound HealingInterferon Type IHumansSignal TransductionSTAT1 Transcription FactorHippo Signaling PathwayPhosphorylationInterferon LambdaCell ProliferationCell MovementInterferon-betaCell LineAnimalsInterleukins

Substanzen

Protein Serine-Threonine KinasesSTAT1 Transcription FactorInterferonsInterferon LambdaLATS1 protein, humanSTAT1 protein, humanInterferon-betainterferon-lambda, humanInterferon Type IInterleukins

Autor:innen und Institutionen

  • Department of Laboratory Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America.
  • Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut, United States of America.
  • Department of Cell Biology, Yale School of Medicine, New Haven, Connecticut, United States of America.
  • Yale Stem Cell Center, Yale School of Medicine, New Haven, Connecticut, United States of America.

ORCID-Profile: Ellen F Foxman

Förderung

  • NHLBI NIH HHS
  • NCATS NIH HHS
  • NIDDK NIH HHS
  • Rita Allen Foundation
  • Mercatus Center, George Mason University
  • National Institutes of Health
  • National Heart, Lung, and Blood Institute
  • Institute of Clinical and Translational Sciences

Zitieren

APA

Subramaniam, K. V., Lim, H. J., Wang, B., Mihaylova, V. T., Thompson, E. N., Krause, D. S., & Foxman, E. F. (2026). Dose-dependent activation of the Hippo pathway by Type I and Type III interferons suppresses tissue repair by human bronchial epithelial cells. PLOS Biology. https://doi.org/10.1371/journal.pbio.3003615

Vancouver

Subramaniam KV, Lim HJ, Wang B, Mihaylova VT, Thompson EN, Krause DS, et al. Dose-dependent activation of the Hippo pathway by Type I and Type III interferons suppresses tissue repair by human bronchial epithelial cells. PLOS Biology. 2026. doi:10.1371/journal.pbio.3003615

BibTeX
@article{Subramaniam2026,
  author = {Subramaniam, Krupakar V and Lim, Hui Jing and Wang, Bao and Mihaylova, Valia T and Thompson, Evrett N and Krause, Diane S and Foxman, Ellen F},
  title = {Dose-dependent activation of the Hippo pathway by Type I and Type III interferons suppresses tissue repair by human bronchial epithelial cells},
  journal = {PLOS Biology},
  year = {2026},
  doi = {10.1371/journal.pbio.3003615}
}
Kostenlos starten →